Amylyx Pharmaceuticals, Inc. AMLX 深 沪
等待开盘 10-08 09:30:00 美东时间
27.43
-0.610
-2.18%
华盛通- 最 高28.46
- 今 开27.72
- 成交量 205.67万股
- 最 低 27.21
- 昨 收 28.04
- 总市值 34.43亿
- 52周最高 41.14
- 市盈率 静 --
- 换手率 1.64%
- 52周最低 10.83
- 委 比 87.91%
- 总股本 1.26亿
- 历史最高 41.9297
- 量 比 1.77
- 振 幅 4.46%
- 历史最低 1.575
- 每 手 1
- 风险率 6.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amylyx Pharma To Present Phase 3 Topline Data Highlighting Avexitide’s Efficacy And Safety At ObesityWeek 2026 Annual Meeting
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced it will present two presentations at the upcoming ObesityWeek® 2026 Annual Meeting, taking place November 14-17, 2026, in Washington, D.C. The first late-breaking oral presentation will feature topline results fro...
10-06 20:07
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
Guggenheim Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $57
Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $55 to $57.
08-27 21:45
美股周涨跌榜 | 研发mRNA癌症疫苗获华尔街齐看好！Moderna周涨129%；MSTR周涨28%
研发mRNA癌症疫苗获华尔街齐看好！Moderna周涨129%；AMLX周涨78%，全球首创GLP-1R拮抗剂三期临床试验成功；比特币大幅反弹突破7.8万美元！MSTR周涨28%>>
08-22 10:20
美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
Why Flexsteel Industries Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Shares of Flexsteel Industries Inc (NASDAQ:FLXS) rose sharply in pre-market trading as the company posted better-than-expected fourth-quarter financial results. The company reported quarterly earnings of $1.33 per share, which beat the analyst consensus estimate of $1.09 per share. The company repor...
08-18 17:01
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) shares are trading higher in Monday’s after-hours session after the company scheduled a Phase 3 trial results readout for this week. Amylyx Pharmaceuticals shares are testing new highs. What’s driving AMLX to record levels? Amylyx Pharma Announces Phase 3 LUC...
08-18 04:53
Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $30
Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and raises the price target from $24 to $30.
08-17 19:27
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
